Literature DB >> 7526713

Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide.

R Grocott-Mason1, P Anning, H Evans, M J Lewis, A M Shah.   

Abstract

Nitric oxide (NO) modulates myocardial contractile behavior in several isolated preparations, e.g., cardiac myocytes and papillary muscles, via elevation of intracellular guanosine 3',5'-cyclic monophosphate (cGMP). We have recently reported that the exogenous NO donor, sodium nitroprusside, selectively modulates left ventricular (LV) relaxation in the isolated ejecting guinea pig heart, independent of coronary flow. We now report the effects of endogenously released NO on LV performance in this preparation (constant heart rate and loading). Both bradykinin (1 nM, n = 6) and substance P (100 nM, n = 6) accelerated early LV relaxation (maximum change in time constant, tE, -10.5 +/- 1.6 and -13.4 +/- 2.1%, respectively; both P < 0.05), without significantly altering early systolic parameters (e.g., rate of LV pressure development). These effects were inhibited by hemoglobin (P < 0.05; n > or = 6), which inactivates NO. Bradykinin (100 nM, n = 10) had an additional negative inotropic effect, which was not inhibited by hemoglobin. Neither agonist altered relaxation in isolated papillary muscles. These data suggest that endogenous NO, probably released from coronary microvascular endothelial cells, modulates LV relaxation in the intact heart.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526713     DOI: 10.1152/ajpheart.1994.267.5.H1804

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  21 in total

1.  Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.

Authors:  J D Sadoff; P M Scholz; J Tse; H R Weiss
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 2.  The role of nitric oxide in sepsis and ARDS: synopsis of a roundtable conference held in Brussels on 18-20 March 1995.

Authors:  M P Fink; D Payen
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

Review 3.  Cardiac dysfunction in sepsis: new theories and clinical implications.

Authors:  R M Grocott-Mason; A M Shah
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

4.  Different left ventricular relaxation parameters in isolated working rat and guinea pig hearts. Influence of preload, afterload, temperature, and isoprenaline.

Authors:  S F Langer; H D Schmidt
Journal:  Int J Card Imaging       Date:  1998-08

5.  Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.

Authors:  L Belhassen; R A Kelly; T W Smith; J L Balligand
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

6.  Nitric oxide and myocardial function in heart failure: friend or foe?

Authors:  J M Cotton; M T Kearney; A M Shah
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

Review 7.  Caveolin: a key target for modulating nitric oxide availability in health and disease.

Authors:  Bikramjit Dhillon; Mitesh V Badiwala; Shu-Hong Li; Ren-Ke Li; Richard D Weisel; Donald A G Mickle; Paul W M Fedak; Vivek Rao; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

8.  Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve.

Authors:  W L Gross; M I Bak; J S Ingwall; M A Arstall; T W Smith; J L Balligand; R A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice.

Authors:  Jorge L Durand; Shankar Mukherjee; Fernando Commodari; Andrea P De Souza; Dazhi Zhao; Fabiana S Machado; Herbert B Tanowitz; Linda A Jelicks
Journal:  Am J Trop Med Hyg       Date:  2009-05       Impact factor: 2.345

10.  Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension.

Authors:  Thiago Quinaglia; Ana Paula C de Faria; Vanessa Fontana; Natália R Barbaro; Andréa R Sabbatini; Jonas T Sertório; Caroline Demacq; José E Tanus-Santos; Heitor Moreno
Journal:  Eur J Clin Pharmacol       Date:  2013-08-21       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.